Prothrombin G20210A and factor V Leiden polymorphisms in stroke

Journal of Molecular Neuroscience

Volumn 46, Issue 1, 2012, Pages 210-216

  They They, Thierry Paluku ^a   Battas, Omar ^a   Slassi, Ilham ^b   Rafai, Mohamed Abdou ^b   Katumbay, Desire Tshala ^c   Nadifi, Sellama ^a  

^a HASSAN II UNIVERSITY   (Morocco)

^b IBN ROCHD UNIVERSITY HOSPITAL   (Morocco)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Factor V Leiden; Genetic polymorphism; Prothrombin; Stroke; Thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; G20210A; PROTHROMBIN; UNCLASSIFIED DRUG;

ALCOHOL CONSUMPTION; AORTA VALVE REGURGITATION; ARTERY OCCLUSION; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE CLASSIFICATION; DNA POLYMORPHISM; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPING TECHNIQUE; HUMAN; HYPERTENSION; INTRACARDIAC THROMBOSIS; ISCHEMIC HEART DISEASE; LACUNAR STROKE; MAJOR CLINICAL STUDY; MITRAL VALVE STENOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; RISK ASSESSMENT; SMOKING; STROKE; THROMBOEMBOLISM; ADULT; AGE; ARTERY DISEASE; BRAIN ISCHEMIA; DISEASE ASSOCIATION; ETHNICITY; FEMALE; GENETIC POLYMORPHISM; MALE; MOROCCO; RISK FACTOR; SEX DIFFERENCE;

ADULT; CASE-CONTROL STUDIES; FACTOR V; FEMALE; HUMANS; MALE; MIDDLE AGED; POINT MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTHROMBIN; RISK FACTORS; STROKE;

EID: 84858281198     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-011-9580-9     Document Type: Article

References (33)

1. Adams HP Jr, Bendixen BH, Kappelle LJ et al (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24:35-41 (Pubitemid 23014379)
2. Arruda V, Annichino-Bizzacchi JM, Gonçalves MS (1997) Prevalence of the prothrombin gene variant (nt20210A) in venous thrombosis and arterial disease. Thromb Haemost 78:1430-1433 (Pubitemid 27519384)
3. Arruda VR, Siquiera LH, Chiaparini LC (1998) Prevalence of the prothrombin gene variant 20210 G→A among patients with myocardial infarction. Cardiovasc Res 37:42-45 (Pubitemid 28122614)
4. Bertina RM, Koeleman BPC, Koster T et al (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64-67 (Pubitemid 24144355)
5. Caprini JA, Glase CJ, Anderson CB, Hathaway K (2004) Laboratory markers in the diagnosis of venous thromboembolism. Circulation 109:14-18
6. Casas JP, Hingorani AD, Bautista LE, Sharma P (2004) Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls. Arch Neurol 61:1652-1662
7. Catto A, Carter A, Ireland H (1995) Factor V Leiden gene mutation and thrombin generation in relation to the development of acute stroke. Arterioscler Thromb Vasc Biol 15:783-785
8. Cavalli Sforza LL, PiazzaA,Menozzi P,Montain J (1988) Reconstruction of human evolution: bringing together genetic, archaeological and linguistic data. Proc Natl Acad Sci U S A 85:6002-6006
9. Croft SA, Daly ME, Steeds RP (1999) The prothrombin 20210A allele and its association with myocardial infarction. Thromb Haemost 81:861-864 (Pubitemid 29312697)
10. Danneberg J, Abbes AP, Bruggeman BJ et al (1998) Reliable genotyping of the G-20210A mutation of coagulation factor II (prothrombin). Clin Chem 44:349-351 (Pubitemid 28087738)
11. Ferrerasi P,Marchetti G, Legnani E (1997) The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increase in frequency in artery disease. Arterioscler Thromb Vasc Biol 17:2418-2422 (Pubitemid 28015976)
12. Gandrille S, Alhenc-Gelas M, Aiach M (1995) A rapid screening method for the factor V Arg→Gln mutation. Blood Coagul Fibrinolysis 6:245
13. Hankey GJ, Eikelboom JW, Van Bockxmeer FM (2001) Inherited thrombophilia in ischemic stroke and its pathogenic subtypes. Stroke 321:1793-1799 (Pubitemid 32772210)
14. Ioannidis JP, Ntzani EE, Trikalinos TA (2004) Racial differences in genetic effects for complex diseases. Nat Genet 36:1243-1244
15. Kim RJ, Becker RC (2003) Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies. Am Heart J 146:948-5
16. Longstreth WT Jr, Rosendaal FR, Siscovick DS et al (1998) Risk of stroke in young women and two prothrombotic mutations: factor V Leiden and prothrombin gene variant (G20210A). Stroke 29:577-580 (Pubitemid 28145781)
17. Madonna P, de Stefano V, Coppola A (2002) Hyperhomocysteinemia and other inherited prothrombotic conditions in young adults with a history of ischemic stroke. Stroke 33:51-56 (Pubitemid 34052184)
18. Margaglione M, D'Andrea G, Giuliani N et al (1999) Inherited prothrombotic conditions and premature ischemic stroke: sex difference in the association with factor V Leiden. Arterioscler Thromb Vasc Biol 19:1751-1756 (Pubitemid 29323835)
19. Markus HS (2003) Stroke genetics clinical neuroscience. Oxford University Press, New York
20. Mathonnet F, Nadifi S, Serazin-Leroy V, Dakouane M, Giudicelli Y (2002) Absence of factor V Leiden mutation and low prothrombin G 20210 A mutation prevalence in a healthy Moroccan population. Thromb Haemost 6(88):1073-1074 (Pubitemid 36018802)
21. Meseguer E, Llamas P, Fernandez de Velasco J et al (2004) Prothrombotic factors in stroke. Neurologia 19:99-105 (Pubitemid 38508385)
22. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
23. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88:3698-3703 (Pubitemid 26383091)
24. Press RD, Liu XY, Beamer N (1996) Ischemic stroke in the elderly: role of the common factor V Leiden mutation causing resistance to activated protein C. Stroke 27:44-48 (Pubitemid 26008293)
25. Putaala J, Metso AJ, Metso TM et al (2009) Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke: the Helsinki young stroke registry. Stroke 40:1195-1203
26. Ridker PM, Hennekens CH, Lindpainter K, Stampfer MJ, Eisenberg PR, Miletich JP (1995) Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke and venous thrombosis in apparently healthy men. N Engl J Med 33:2912-2917
27. Ridker PM, Hennekens CH, Miletich JP (1999) G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men. Circulation 99:999-1004 (Pubitemid 29104487)
28. Rosendaal FR, Siscovick DS, Schwartz SM (1997) A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women. Blood 90:1747-1750 (Pubitemid 27377284)
29. Szolnoki Z, Somogyvari F, Kondacs A, Szabo M, Fodor L (2002) Evaluation of the interactions of common genetic mutations in stroke subtypes. J Neurol 249:1391-1397 (Pubitemid 35217660)
30. Voetsch B, Damasceno BP, Camargo ECS et al (2000) Inherited thrombophilia as a risk factor for the development of ischemic stroke in young adults. Thromb Haemost 83:229-233 (Pubitemid 30093224)
31. Webster MWI, Smith HJ, Sharpe DN et al (1988) Patent foramen ovale in young stroke patients. Lancet 332:11-12
32. Zenz W (1998) Factor V Leiden and prothrombin gene G 20210 A variant in children with ischemic stroke. Thromb Haemost 80:763-766
33. Zhang F, Wang Y, Deng HW (2008) Comparison of population-based association study methods correcting for population stratification. PLoS ONE 3:3392